These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36940778)

  • 1. Examining neurobehavioral differences that support success in recovery from alcohol and other substance use disorders.
    Satyal MK; Basso JC; Wilding H; Athamneh LN; Bickel WK
    J Subst Use Addict Treat; 2023 May; 148():209007. PubMed ID: 36940778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in temporal discounting, hedonic hunger, and food addiction during recovery from substance misuse.
    Basso JC; Satyal MK; Athamneh L; Bickel WK
    Appetite; 2022 Feb; 169():105834. PubMed ID: 34871591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recovery schools for improving behavioral and academic outcomes among students in recovery from substance use disorders: a systematic review.
    Hennessy EA; Tanner-Smith EE; Finch AJ; Sathe N; Kugley S
    Campbell Syst Rev; 2018; 14(1):1-86. PubMed ID: 37131375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The phenotype of recovery VII: Delay discounting mediates the relationship between time in recovery and recovery progress.
    Craft WH; Tegge AN; Athamneh LN; Tomlinson DC; Freitas-Lemos R; Bickel WK
    J Subst Abuse Treat; 2022 May; 136():108665. PubMed ID: 34895955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The phenotype of recovery VIII: Association among delay discounting, recovery capital, and length of abstinence among individuals in recovery from substance use disorders.
    Keith DR; Tegge AN; Athamneh LN; Freitas-Lemos R; Tomlinson DC; Craft WH; Bickel WK
    J Subst Abuse Treat; 2022 Aug; 139():108783. PubMed ID: 35562317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The phenotype of recovery III: Delay discounting predicts abstinence self-efficacy among individuals in recovery from substance use disorders.
    Athamneh LN; DeHart WB; Pope D; Mellis AM; Snider SE; Kaplan BA; Bickel WK
    Psychol Addict Behav; 2019 May; 33(3):310-317. PubMed ID: 30896193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The phenotype of recovery V: Does delay discounting predict the perceived risk of relapse among individuals in recovery from alcohol and drug use disorders.
    Turner JK; Athamneh LN; Basso JC; Bickel WK
    Alcohol Clin Exp Res; 2021 May; 45(5):1100-1108. PubMed ID: 33742491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The phenotype of recovery II: The association between delay discounting, self-reported quality of life, and remission status among individuals in recovery from substance use disorders.
    Athamneh LN; Freitas Lemos R; Basso JC; Tomlinson DC; Craft WH; Stein MD; Bickel WK
    Exp Clin Psychopharmacol; 2022 Feb; 30(1):59-72. PubMed ID: 33001696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The phenotype of recovery VI: The association between life-history strategies, delay discounting, and maladaptive health and financial behaviors among individuals in recovery from alcohol use disorders.
    Athamneh LN; Freitas-Lemos R; Basso JC; Keith DR; King MJ; Bickel WK
    Alcohol Clin Exp Res; 2022 Jan; 46(1):129-140. PubMed ID: 35076945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations between delay discounting and unhealthy behaviors in substance use recovery.
    Cabral DAR; Tegge AN; Dwyer CL; Quddos F; Kaur RP; Nguyen J; Athamneh L; Bickel WK
    Drug Alcohol Depend; 2024 Sep; 262():111395. PubMed ID: 39053430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Associations between Remission Status, Discounting Rates, and Recovery from Substance Use Disorders.
    Athamneh LN; King MJ; Craft WH; Freitas-Lemos R; Tomlinson DC; Yeh YH; Bickel WK
    Subst Use Misuse; 2023; 58(2):275-282. PubMed ID: 36622296
    [No Abstract]   [Full Text] [Related]  

  • 12. Rate-dependent effects of narrative interventions in a longitudinal study of individuals who use alcohol.
    Craft WH; Dwyer CL; Tomlinson DC; Yeh YH; Tegge AN; Bickel WK
    Alcohol Clin Exp Res (Hoboken); 2023 Mar; 47(3):566-576. PubMed ID: 36810763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between parental history and delay discounting among individuals in recovery from addiction.
    Athamneh LN; Stein JS; Quisenberry AJ; Pope D; Bickel WK
    Drug Alcohol Depend; 2017 Oct; 179():153-158. PubMed ID: 28780380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does delay discounting predict maladaptive health and financial behaviors in smokers?
    Snider SE; DeHart WB; Epstein LH; Bickel WK
    Health Psychol; 2019 Jan; 38(1):21-28. PubMed ID: 30474996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early life adversity and increased delay discounting: Findings from the Family Health Patterns project.
    Acheson A; Vincent AS; Cohoon A; Lovallo WR
    Exp Clin Psychopharmacol; 2019 Apr; 27(2):153-159. PubMed ID: 30556730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The phenotype of recovery IV: Delay discounting predicts perceived stress and a chance locus of control in individuals in recovery from substance use disorders.
    Tomlinson DC; Tegge AN; Athamneh LN; Bickel WK
    Addict Behav Rep; 2020 Dec; 12():100320. PubMed ID: 33364328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Problem and Pathological Gambling in Schizophrenia: Exploring Links with Substance Use and Impulsivity.
    Fortgang RG; Hoff RA; Potenza MN
    J Gambl Stud; 2018 Sep; 34(3):673-688. PubMed ID: 29453588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroeconomics and adolescent substance abuse: individual differences in neural networks and delay discounting.
    Stanger C; Elton A; Ryan SR; James GA; Budney AJ; Kilts CD
    J Am Acad Child Adolesc Psychiatry; 2013 Jul; 52(7):747-755.e6. PubMed ID: 23800488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Phenotype of Recovery X: Associations between delay discounting, regulatory flexibility, and remission from substance use disorder.
    Dwyer CL; Tegge AN; Craft WH; Tomlinson DC; Athamneh LN; Bickel WK
    J Subst Use Addict Treat; 2023 Dec; 155():209122. PubMed ID: 37451516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Additive roles of tobacco and cannabis co-use in relation to delay discounting in a sample of heavy drinkers.
    Nieto SJ; Venegas A; Burnette EM; MacKillop J; Ray LA
    Psychopharmacology (Berl); 2022 May; 239(5):1387-1395. PubMed ID: 34652499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.